XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
3 Months Ended 9 Months Ended 120 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract]          
Research and development expenses, net $ 469,836 $ 461,077 $ 1,423,364 $ 1,242,191 $ 9,979,078
General and administrative expenses 216,190 239,169 664,738 493,905 2,826,472
Other income             (912)
Operating loss 686,026 700,246 2,088,102 1,736,096 12,804,638
Financing (income) expenses, net 14,530 8,462 (15,135) 29,533 1,785,848
Loss for the period 700,556 708,708 2,072,967 1,765,629 14,590,486
Other comprehensive (income) loss:          
Foreign currency translation adjustment 8,069 (42,384) (13,074) (42,408) (35,708)
Comprehensive loss $ 708,625 $ 666,324 $ 2,059,893 $ 1,723,221 $ 14,554,778
Loss per share (Basic and Diluted) (Note 4) $ 0.13 $ 0.14 $ 0.39 $ 0.35  
Weighted average number of shares outstanding (Basic and Diluted) (Note 4) 5,295,543 5,205,640 5,295,543 5,016,935